Current immunotherapy for solid tumors

Immunotherapy
Lisbeth Barkholt, Marco Bregni

Abstract

Explorative knowledge of cellular and molecular mechanisms of immune function and regulation has provided optimism in developing cancer immunotherapy. However, three decades of experimental and clinical investigations to offer powerful immunotherapeutic strategies against solid tumors, with the possible exception of monoclonal antibody-targeted therapies, have not succeeded in significantly prolonging patient survival. Nonspecific immune approaches, including cytokine-based therapies and allogeneic hematopoietic stem cell transplantation, have so far produced consistent, although limited, results. In this review, we present the developments of cell transfer-based strategies that, in preclinical studies, have demonstrated potential efficacy, but have only established tumor regression in limited numbers of patients. The key to success demands creative combinations of tumor antigens, adjuvance, gene modification and various administration strategies in the development of cell-based therapies together with other cancer-treatment principles, often in a stepwise 'space-rocket-type' approach. Combined efforts of several scientific disciplines, such as tumor biology and immunology, as well as cell and gene research in transplantation, ...Continue Reading

References

Jul 14, 1995·Cell·N K Nanda, E E Sercarz
Sep 1, 1995·Cellular Immunology·G E PeoplesT J Eberlein
Feb 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J KennedyN E Davidson
Oct 6, 1997·Bone Marrow Transplantation·J L ByrneN H Russell
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N T UenoR E Champlin
Nov 17, 1998·The Journal of Urology·C A HaasF W Abdul-Karim
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R W ChildsJ Barrett
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary L DisisKathy Schiffman
Jun 3, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stefan W KrauseGabriele Multhoff
Mar 4, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas LeemhuisRobert S Negrin
Mar 16, 2005·Current Opinion in Immunology·Loredana RuggeriAndrea Velardi
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark E DudleySteven A Rosenberg
Jul 13, 2005·Cancer Immunology, Immunotherapy : CII·K L Knutson, M L Disis
Mar 2, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Md Z DewanN Yamamoto
May 2, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L BarkholtUNKNOWN French ITAC group and the EBMT Solid Tumour Working Party
Sep 2, 2006·Science·Richard A MorganSteven A Rosenberg
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas MackensenReinhard Andreesen

❮ Previous
Next ❯

Methods Mentioned

BETA
lymphodepletion
leukapheresis
biopsy
genetic modification

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.